Polianta Ltd Reduces Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Polianta Ltd lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 1.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,500 shares of the pharmacy operator’s stock after selling 500 shares during the period. Walgreens Boots Alliance makes up approximately 0.6% of Polianta Ltd’s investment portfolio, making the stock its 20th biggest position. Polianta Ltd’s holdings in Walgreens Boots Alliance were worth $1,083,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Candriam Luxembourg S.C.A. raised its stake in shares of Walgreens Boots Alliance by 0.5% during the first quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock valued at $2,842,000 after acquiring an additional 310 shares in the last quarter. Signet Financial Management LLC raised its stake in Walgreens Boots Alliance by 1.0% in the first quarter. Signet Financial Management LLC now owns 35,461 shares of the pharmacy operator’s stock worth $1,588,000 after buying an additional 334 shares in the last quarter. Vantage Consulting Group Inc raised its stake in Walgreens Boots Alliance by 1.7% in the second quarter. Vantage Consulting Group Inc now owns 20,759 shares of the pharmacy operator’s stock worth $591,000 after buying an additional 344 shares in the last quarter. Syntax Advisors LLC raised its stake in Walgreens Boots Alliance by 1.7% in the second quarter. Syntax Advisors LLC now owns 20,759 shares of the pharmacy operator’s stock worth $591,000 after buying an additional 344 shares in the last quarter. Finally, Cooper Financial Group raised its stake in Walgreens Boots Alliance by 4.2% in the third quarter. Cooper Financial Group now owns 10,982 shares of the pharmacy operator’s stock worth $244,000 after buying an additional 442 shares in the last quarter. Hedge funds and other institutional investors own 57.92% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of WBA stock traded up $0.20 during mid-day trading on Friday, hitting $20.82. 15,864,922 shares of the stock were exchanged, compared to its average volume of 14,337,902. The firm has a fifty day moving average of $22.23 and a 200 day moving average of $22.42. The company has a quick ratio of 0.30, a current ratio of 0.66 and a debt-to-equity ratio of 0.27. Walgreens Boots Alliance, Inc. has a 52-week low of $19.68 and a 52-week high of $36.58. The company has a market cap of $17.95 billion, a PE ratio of 31.55, a price-to-earnings-growth ratio of 1.30 and a beta of 0.73.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its earnings results on Thursday, January 4th. The pharmacy operator reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.62 by $0.04. Walgreens Boots Alliance had a net margin of 0.40% and a return on equity of 10.48%. The business had revenue of $36.70 billion for the quarter, compared to analyst estimates of $34.95 billion. During the same period in the prior year, the company posted $1.16 EPS. The company’s revenue for the quarter was up 9.9% on a year-over-year basis. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.24 earnings per share for the current year.

Walgreens Boots Alliance Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 12th. Investors of record on Tuesday, February 20th were given a dividend of $0.25 per share. The ex-dividend date was Friday, February 16th. This represents a $1.00 annualized dividend and a dividend yield of 4.80%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 151.52%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. HSBC reissued a “reduce” rating and issued a $20.00 price objective (down previously from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. TheStreet raised Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research report on Monday, January 8th. Barclays initiated coverage on Walgreens Boots Alliance in a research report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price target on the stock. Finally, SVB Leerink started coverage on Walgreens Boots Alliance in a research report on Monday, February 26th. They set a “market perform” rating and a $23.00 price target on the stock. Three analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $25.83.

View Our Latest Stock Analysis on WBA

Insider Buying and Selling

In other Walgreens Boots Alliance news, Director Valerie B. Jarrett acquired 4,456 shares of the business’s stock in a transaction on Monday, January 29th. The stock was bought at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the acquisition, the director now owns 4,456 shares in the company, valued at $99,992.64. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CEO Timothy C. Wentworth purchased 10,000 shares of the company’s stock in a transaction dated Friday, January 5th. The stock was acquired at an average price of $24.22 per share, with a total value of $242,200.00. Following the purchase, the chief executive officer now directly owns 585,122 shares in the company, valued at approximately $14,171,654.84. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Also, Director Valerie B. Jarrett purchased 4,456 shares of the company’s stock in a transaction dated Monday, January 29th. The stock was purchased at an average cost of $22.44 per share, with a total value of $99,992.64. Following the purchase, the director now owns 4,456 shares in the company, valued at $99,992.64. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.